Antonia Zapata del Baño is a Biotechnologist by academic training from University of Murcia, Spain. She works as a Specialist in Analytical Development at Nanopharm Ltd., an Aptar Pharma Company. Since joining Nanopharm in 2019, she has built broad expertise across respiratory and nasal drug delivery, taking on a range of roles within the field. Her work has focused particularly on the development of pressurised metered-dose inhalers (pMDIs), while also contributing to projects involving dry powder inhalers (DPIs) and nasal spray products
